Podcast
OnFocus Podcast: Michael Hoey
April 27, 2022
Francis Medical Founder and Chief Technology Officer, Michael Hoey, was recently featured on OnFocus, a podcast by The Focal Therapy Clinic in the UK.
Click below to hear Michael talk about his personal journey into discovering and developing water vapor therapy for treating the prostate and why he’s so committed to innovating in this space.
Original episode post and transcript
Supplemental Article: Key Trends Driving Progress in Focal Therapy
Learn more about water vapor therapy
Recent Posts
Francis Medical Receives FDA 510(k) Clearance for Use of the Vanquish® Water Vapor System for Prostate Tissue Ablation
MINNEAPOLIS (Dec. 2, 2025) – Francis Medical, Inc.,a privately-held medical device company developing the breakthrough Vanquish® Water Vapor Ablation System
Press Release: Francis Medical Announces Completion of Enrollment in the VAPOR 2 Pivotal Study for Vanquish Prostate Cancer Treatment
February 25, 2025: Francis Medical completes enrollment in the company's VAPOR 2 Pivotal Study for Vanquish Prostate Cancer Treatment
Press Release: Francis Medical Announces Close of Record $80 Million Series C Equity Financing
January 8, 2025: Francis Medical raises record $80M in Series C to fund its VAPOR 2 study and U.S. launch of Vanquish, its proprietary prostate cancer treatment
Federal law (USA) restricts this device to sale by or on the order of a physician.
Refer to the device User Manual for a list of contraindications, warnings, and cautions.
Training: Do not operate the Vanquish System without completing Francis Medical-provided physician training. Untrained operation of the device may lead to improper use. Improper use can result in patient injury or equipment malfunction.